Diabetes &
Primary Care

Issue:

Vol:24 | No:01

Share this article

↓ Download pdf

Need to know guide: Dosing for direct-acting oral anticoagulants in non-valvular atrial fibrillation

Yassir Javaid, Pam Brown

GPwSI in Cardiology, Northampton, GP, Swansea

A printable guide to the considerations of prescribing a DOAC drug in atrial fibrillation.

Save, Share, Print Article

Share this article

↓ Download pdf

Need to know is a series of rapid-reference memory aids from Diabetes & Primary Care. This guide summarises what to consider when prescribing a DOAC drug to an individual, and includes how to calculate creatinine clearance.

Readers are directed to the PDF version.

Cardiovascular disease, Clinical guidance, Comorbidities, Editor's Pick, Need to know

Diabetes &
Primary Care

Need to know guide: Dosing for direct-acting oral anticoagulants in non-valvular atrial fibrillation

At a glance factsheet: Gastrointestinal side-effects of incretin mimetics

Diabetes Distilled: Atorvastatin for primary cardiovascular prevention reduces major events but not disability-free survival in older adults

A quality improvement initiative to improve the care of women diagnosed with gestational diabetes

Editorial: Incretin therapies: Suitable for people with type 1 diabetes?

PCDO Society news: Response to proposed NICE indicator on semaglutide for cardiovascular disease

International Congress on Obesity 2026: Incretin therapies, cardiovascular risk and excessive gestational weight gain

Case report: Diabetic ketoacidosis – a rare but serious side-effect of SGLT2 inhibitors